Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study
- PMID: 9363034
- DOI: 10.1016/s0895-4356(97)00119-4
Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study
Abstract
The aim of the study was to analyze cardiovascular risk factors as predictors for developing non-insulin-dependent diabetes mellitus (NIDDM) in people with impaired glucose tolerance. A cross-sectional survey of glucose tolerance was conducted in people, aged 50-74, who were randomly selected from the registry of the middle-sized town Hoorn (The Netherlands). Based on the mean values of two oral glucose tolerance tests, people were classified in glucose tolerance categories according to the WHO criteria. The mean follow-up time was 36 months (range 13-55 months). The cumulative incidence of NIDDM was 34% (95% CI 16.9-45.1). In multiple logistic regression analysis, cardiovascular risk factors at baseline did not predict the conversion from impaired glucose tolerance to NIDDM, in contrast with the two-hour plasma glucose level (odds ratio 3.56, p < 0.001) and the fasting proinsulin level, as one of the determinants of beta-cell dysfunction (Odds ratio 2.1, p < 0.05). The baseline HDL-cholesterol level, one of the components of the insulin resistance syndrome, was associated with the conversion from impaired glucose tolerance to normal glucose tolerance (Odds ratio 1.58, p < 0.05). The results of our study seem to support the hypothesis that conversion from impaired glucose tolerance to normal glucose tolerance depends on insulin resistance and the development of NIDDM from impaired glucose tolerance depends on beta-cell dysfunction.
Similar articles
-
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.Diabetologia. 1996 Jan;39(1):113-8. doi: 10.1007/BF00400421. Diabetologia. 1996. PMID: 8720611
-
Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.Diabetes Care. 1997 Jul;20(7):1101-7. doi: 10.2337/diacare.20.7.1101. Diabetes Care. 1997. PMID: 9203444
-
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28. J Clin Endocrinol Metab. 2013. PMID: 23539736 Clinical Trial.
-
Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.Eur J Clin Invest. 1998 Sep;28 Suppl 2:8-13. doi: 10.1046/j.1365-2362.1998.0280s2008.x. Eur J Clin Invest. 1998. PMID: 9777321 Review.
-
Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.Sports Med. 1997 Nov;24(5):321-36. doi: 10.2165/00007256-199724050-00004. Sports Med. 1997. PMID: 9368278 Review.
Cited by
-
The cost of diabetes Type II in Europe: the CODE-2 Study.Diabetologia. 2002 Jul;45(7):S1-4. doi: 10.1007/s00125-002-0860-3. Epub 2002 May 24. Diabetologia. 2002. PMID: 12136404 No abstract available.
-
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD012661. doi: 10.1002/14651858.CD012661.pub2. Cochrane Database Syst Rev. 2018. PMID: 30371961 Free PMC article.
-
Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.J Mol Med (Berl). 2012 May;90(5):575-85. doi: 10.1007/s00109-011-0834-3. Epub 2011 Nov 22. J Mol Med (Berl). 2012. PMID: 22105852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical